Cancer Research Targets Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boudjelal, M.
Right arrow Articles by Fisher, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boudjelal, M.
Right arrow Articles by Fisher, G. J.
[Cancer Research 60, 2247-2252, April 15, 2000]
© 2000 American Association for Cancer Research

Molecular Biology and Genetics

Ubiquitin/Proteasome Pathway Regulates Levels of Retinoic Acid Receptor {gamma} and Retinoid X Receptor {alpha} in Human Keratinocytes1

Mohamed Boudjelal, Zengquan Wang, John J. Voorhees and Gary J. Fisher2

Department of Dermatology, University of Michigan, Ann Arbor, Michigan 48109

Repeated exposure of human skin to solar UV radiation leads to premature aging (photoaging) and skin cancer. UV-induced skin damage can be ameliorated by all-trans retinoic acid treatment. The actions of retinoic acid in skin keratinocytes are mediated primarily by nuclear retinoic acid receptor {gamma} (RAR{gamma}) and retinoid X receptor {alpha} (RXR{alpha}). We found that exposure of cultured primary human keratinocytes to UV irradiation (30 mJ/cm2) substantially reduced (50–90%) RAR{gamma} and RXR{alpha} mRNA and protein within 8 h. The rates of disappearance of RAR{gamma} and RXR{alpha} proteins after UV exposure or treatment with the protein synthesis inhibitor cycloheximide were similar. UV irradiation did not increase the rate of breakdown of RAR{gamma} or RXR{alpha} but rather reduced their rate of synthesis. The addition of proteasome inhibitors MG132 and LLvL, but not the lysosomal inhibitor E64, prevented loss of RAR{gamma} and RXR{alpha} proteins after exposure of keratinocytes to either UV radiation or cycloheximide. Soluble extracts from nonirradiated or UV-irradiated keratinocytes possessed similar levels of proteasome activity that degraded RAR{gamma} and RXR{alpha} proteins in vitro. Furthermore, RAR{gamma} and RXR{alpha} were polyubiquitinated in intact cells. RXR{alpha} was found to contain two proline, glutamate/aspartate, serine, and threonine (PEST) motifs, which confer rapid turnover of many short-lived regulatory proteins that are degraded by the ubiquitin/proteasome pathway. However, the PEST motifs in RXR{alpha} did not function to regulate its stability, because deletion of the PEST motifs individually or together did not alter ubiquitination or proteasome-mediated degradation of RXR{alpha}. These results demonstrate that loss of RAR{gamma} and RXR{alpha} proteins after UV irradiation results from degradation via the ubiquitin/proteasome pathway. Taken together, the data here indicate that ubiquitin/proteasome-mediated breakdown is an important mechanism regulating the levels of nuclear retinoid receptors.




This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
J.-H. Man, H.-Y. Li, P.-J. Zhang, T. Zhou, K. He, X. Pan, B. Liang, A.-L. Li, J. Zhao, W.-L. Gong, et al.
PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its retention in the nucleus
Nucleic Acids Res., November 14, 2006; 34(19): 5552 - 5566.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
Y. Tateishi, R. Sonoo, Y.-i. Sekiya, N. Sunahara, M. Kawano, M. Wayama, R. Hirota, Y.-i. Kawabe, A. Murayama, S. Kato, et al.
Turning Off Estrogen Receptor {beta}-Mediated Transcription Requires Estrogen-Dependent Receptor Proteolysis
Mol. Cell. Biol., November 1, 2006; 26(21): 7966 - 7976.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. D.-C. Arce, U. Soto, J. van Riggelen, E. Schwarz, H. z. Hausen, and F. Rosl
Ectopic Expression of Nonliganded Retinoic Acid Receptor {beta} Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
J. Biol. Chem., October 29, 2004; 279(44): 45408 - 45416.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. N. Moraitis and V. Giguere
The Co-repressor Hairless Protects ROR{alpha} Orphan Nuclear Receptor from Proteasome-mediated Degradation
J. Biol. Chem., December 26, 2003; 278(52): 52511 - 52518.
[Abstract] [Full Text] [PDF]

Home page
 Eukaryot CellHome page
E. Villalobo, C. Moch, G. Fryd-Versavel, A. Fleury-Aubusson, and L. Morin
Cysteine Proteases and Cell Differentiation: Excystment of the Ciliated Protist Sterkiella histriomuscorum
Eukaryot. Cell, December 1, 2003; 2(6): 1234 - 1245.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Woodham, L. Birch, and G. S. Prins
Neonatal Estrogen Down-Regulates Prostatic Androgen Receptor through a Proteosome-Mediated Protein Degradation Pathway
Endocrinology, November 1, 2003; 144(11): 4841 - 4850.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Chauchereau, L. Amazit, M. Quesne, A. Guiochon-Mantel, and E. Milgrom
Sumoylation of the Progesterone Receptor and of the Steroid Receptor Coactivator SRC-1
J. Biol. Chem., March 28, 2003; 278(14): 12335 - 12343.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. Wormke, M. Stoner, B. Saville, K. Walker, M. Abdelrahim, R. Burghardt, and S. Safe
The Aryl Hydrocarbon Receptor Mediates Degradation of Estrogen Receptor {alpha} through Activation of Proteasomes
Mol. Cell. Biol., March 15, 2003; 23(6): 1843 - 1855.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. K. Fung, W. Y. Siu, C. H. Yam, A. Lau, and R. Y. C. Poon
Cyclin F Is Degraded during G2-M by Mechanisms Fundamentally Different from Other Cyclins
J. Biol. Chem., September 13, 2002; 277(38): 35140 - 35149.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Boskovic, D. Desai, and R. M. Niles
Regulation of Retinoic Acid Receptor alpha by Protein Kinase C in B16 Mouse Melanoma Cells
J. Biol. Chem., July 12, 2002; 277(29): 26113 - 26119.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
K. Prufer, C. Schroder, K. Hegyi, and J. Barsony
Degradation of RXRs Influences Sensitivity of Rat Osteosarcoma Cells to the Antiproliferative Effects of Calcitriol
Mol. Endocrinol., May 1, 2002; 16(5): 961 - 976.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
D. L. Osburn, G. Shao, H. M. Seidel, and I. G. Schulman
Ligand-Dependent Degradation of Retinoid X Receptors Does Not Require Transcriptional Activity or Coactivator Interactions
Mol. Cell. Biol., August 1, 2001; 21(15): 4909 - 4918.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. M. Shin, F. R. Khuri, B. Murphy, A. S. Garden, G. Clayman, M. Francisco, D. Liu, B. S. Glisson, L. Ginsberg, V. Papadimitrakopoulou, et al.
Combined Interferon-Alfa, 13-cis-Retinoic Acid, and Alpha-Tocopherol in Locally Advanced Head and Neck Squamous Cell Carcinoma: Novel Bioadjuvant Phase II Trial
J. Clin. Oncol., June 15, 2001; 19(12): 3010 - 3017.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X.-C. Xu, W. Y. L. Wong, L. Goldberg, S. C. Baer, J. E. Wolf, W. M. Ramsdell, D. S. Alberts, S. M. Lippman, and R. Lotan
Progressive Decreases in Nuclear Retinoid Receptors during Skin Squamous Carcinogenesis
Cancer Res., June 1, 2001; 61(11): 4306 - 4310.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Lehmann, C. Paul, and H. Törmä
Retinoid Receptor Expression and Its Correlation to Retinoid Sensitivity in Non-M3 Acute Myeloid Leukemia Blast Cells
Clin. Cancer Res., February 1, 2001; 7(2): 367 - 373.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. M. Clayton, S. Y. Peak-Chew, R. M. Evans, and J. W. R. Schwabe
The structure of the ultraspiracle ligand-binding domain reveals a nuclear receptor locked in an inactive conformation
PNAS, February 1, 2001; (2001) 41611298.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. M. Clayton, S. Y. Peak-Chew, R. M. Evans, and J. W. R. Schwabe
The structure of the ultraspiracle ligand-binding domain reveals a nuclear receptor locked in an inactive conformation
PNAS, February 13, 2001; 98(4): 1549 - 1554.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.